<DOC>
	<DOCNO>NCT01620125</DOCNO>
	<brief_summary>Recent data suggest trillion bacteria investigator gastrointestinal tract ( gut microbiota ) function environmental factor modulates amount body fat . Obese individual alter gut microbiota germ-free mouse resistant develop diet-induced obesity lower fast insulin glucose improve glucose tolerance . Administration probiotic bacterium Lactobacillus strain ferment milk 12 week reduce adiposity body weight obese adult , possibly reduce lipid absorption inflammatory status . However , study investigator knowledge address whether probiotic supplementation improve glucose metabolism type 2 diabetes patient .</brief_summary>
	<brief_title>Metabolic Control Before After Supplementation With Lactobacillus Reuteri DSM 17938 Type 2 Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<criteria>Type 2 diabetes duration &gt; 6 month Abdominal obesity HbA1c 5080 mmol/mol Written inform consent Stated availability throughout study period Autoimmune diabetes eg type 1 diabetes Psychiatric illness cancer diagnosis No foreseeable need treatment corticosteroid antibiotic Inflammatory bowel disease Administration antibiotics 4 week inclusion Administration probiotic 2 week inclusion Participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Lactobacillus</keyword>
	<keyword>Gut microbiota</keyword>
	<keyword>Diabetes mellitus</keyword>
</DOC>